Transplant News and Research RSS Feed - Transplant News and Research

HICCC receives $18 million grant from the National Cancer Institute

HICCC receives $18 million grant from the National Cancer Institute

Outstanding basic research, a growing focus on translating discoveries into treatments, and a dedication to patient care have earned the Herbert Irving Comprehensive Cancer Center (HICCC) of Columbia University Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 million, five-year Cancer Center Support Grant from the National Cancer Institute (NCI). [More]
Scientists grow fully functional organ in animal from transplanted laboratory-created cells

Scientists grow fully functional organ in animal from transplanted laboratory-created cells

Laboratory-grown replacement organs have moved a step closer with the completion of a new study. Scientists have grown a fully functional organ from transplanted laboratory-created cells in a living animal for the first time. [More]
Research to determine breath test's effectivness in patient with COPD

Research to determine breath test's effectivness in patient with COPD

NYU Langone Medical Center will lead a new clinical initiative -- funded by a $225,000 grant from The National Institutes of Health -- to determine a breath test's effectivness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstrutive pulmonary disease (COPD). [More]
Heart-lung support technology increases number of kidneys, livers, pancreases for transplant

Heart-lung support technology increases number of kidneys, livers, pancreases for transplant

Using heart-lung support technology, the University of Michigan's Transplant Center was able to increase the number of kidneys, livers and pancreases available for transplant by about 20 percent. [More]
New BioInformant report finds 21-fold increase in companies involved in cord blood banking industry

New BioInformant report finds 21-fold increase in companies involved in cord blood banking industry

As a leading provider of market research, MarketResearch.com is pleased to announce the distribution of a new BioInformant Worldwide, L.L.C. report that found a 21-fold increase (2,100%) in the companies involved in the cord blood banking industry in the past 10 years. [More]
Houston Methodist researchers receive $1.6M from NIH to study pathological antibodies

Houston Methodist researchers receive $1.6M from NIH to study pathological antibodies

Transplant immunologists at the Houston Methodist Research Institute will receive about $1.6 million over four years from the National Institute of Allergy and Infectious Diseases to study pathological antibodies produced from activated memory B cells during the chronic rejection of organ transplants. [More]
Study confirms close link between immune system and adult neurogenesis

Study confirms close link between immune system and adult neurogenesis

A new study by Barbara Beltz, the Allene Lummis Russell Professor of Neuroscience at Wellesley College, and Irene Soderhall of Uppsala University, Sweden, published in the August 11 issue of the journal Developmental Cell, demonstrates that the immune system can produce cells with stem cell properties, using crayfish as a model system. These cells can, in turn, create neurons in the adult animal. [More]
New contact lens microbiology workshop aims at preventing Acanthamoeba keratitis

New contact lens microbiology workshop aims at preventing Acanthamoeba keratitis

The American Academy of Ophthalmology today announced a contact lens microbiology workshop on Sept. 12 aimed at preventing Acanthamoeba keratitis, a rare infection among contact lens wearers that causes severe eye pain, redness, light sensitivity and potential vision loss. [More]
Researchers compare benefits of bivalirudin and heparin for patients undergoing coronary stenting

Researchers compare benefits of bivalirudin and heparin for patients undergoing coronary stenting

Bivalirudin and heparin are two anticoagulant options for patients undergoing coronary stenting for ischemic heart disease. Bivalirudin, a newer anticoagulant, has been touted as being as effective as generic heparin, but with nearly half the rate of bleeding. [More]
High-intensity exercise can help stable heart transplant patients

High-intensity exercise can help stable heart transplant patients

High-intensity exercise can help stable heart transplant patients reach higher levels of exercise capacity, and gain better control of their blood pressure than moderate intensity exercise, investigators report in a new study published in the American Journal of Transplantation. [More]
Researchers reveal how early changes in DNA methylation involved in Alzheimer's disease

Researchers reveal how early changes in DNA methylation involved in Alzheimer's disease

A new study led by researchers at Brigham and Women's Hospital (BWH) and Rush University Medical Center, reveals how early changes in brain DNA methylation are involved in Alzheimer's disease. [More]
Paediatric PAH treatment goals identified

Paediatric PAH treatment goals identified

Researchers from the Netherlands have identified three baseline variables that may qualify as treatment goals in children with pulmonary arterial hypertension. [More]
First Edition: August 14, 2014

First Edition: August 14, 2014

Today's headlines include a report about an uptick in VA referrals to private physicians. Kaiser Health News staff writer Julie Appleby reports: "Some hospitals in New York, Florida and Wisconsin are exploring ways to help individuals and families pay their share of the costs of government-subsidized policies purchased though the health law's marketplaces – at least partly to guarantee the hospitals get paid when the consumers seek care. [More]
Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

Combination of NASBA and real-time qPCR detects aspergillosis with 100% accuracy

The fungal infection invasive aspergillosis (IA) can be life threatening, especially in patients whose immune systems are weakened by chemotherapy or immunosuppressive drugs. Despite the critical need for early detection, IA remains difficult to diagnose. [More]
Decline in daily functioning linked with Alzheimer's disease is related to alterations in brain activity

Decline in daily functioning linked with Alzheimer's disease is related to alterations in brain activity

Decline in daily functioning associated with Alzheimer's disease is related to alterations in activity in certain regions of the brain, according to a study published in the August 2014 issue of the Journal of Alzheimer's Disease. [More]
Experts to debate healthy labor and delivery practices at Cedars-Sinai Birth Community Day

Experts to debate healthy labor and delivery practices at Cedars-Sinai Birth Community Day

Doctors, nurses, midwives and doulas will debate healthy labor and delivery practices - including the use of the synthetic hormone Pitocin to hasten childbirth and vitamin K to speed blood clotting in newborns -- at the third annual Cedars-Sinai Birth Community Day, Aug. 14. [More]
UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

The University of Chicago Medicine and Advocate Children's Hospital / Advocate Health Care have received a five-year, $1.8-million grant from the National Institutes of Health to find new ways to delay and prevent type 1 diabetes. The grant will establish the first Type 1 Diabetes TrialNet Clinical Center in Chicago. [More]
Patient with mechanical heart pump receives new gene therapy for heart failure

Patient with mechanical heart pump receives new gene therapy for heart failure

For the first time in the world, a patient with a mechanical heart pump has received a new gene therapy for heart failure at Harefield Hospital, London. [More]
University of Chicago adds six new members to governing Board of Trustees

University of Chicago adds six new members to governing Board of Trustees

The University of Chicago Medical Center added six new members to its governing Board of Trustees, and named a new president of the medical staff. [More]
3SBio enters into exclusive license with DiNonA for development of Leukotuximab

3SBio enters into exclusive license with DiNonA for development of Leukotuximab

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with DiNonA Inc. for the development, manufacturing and marketing of Leukotuximab, an anti JL-1 antibody for acute leukemia (AL), including acute myelocytic leukemia (AML) and acute lymphoblastic leukemia (ALL), in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and the Middle East (excluding Cyprus, Egypt, Israel and Turkey). [More]